Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 09, 2025, titled "Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA? in India to Advance Treatment of Hematological Malignancies".
Press Release Jun 09 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Jun 02 2025
- Press Release May 23 2025
- Press Release May 05 2025
- Press Release Apr 16 2025
- Press Release Apr 01 2025
Later from Glenmark Pharmaceuticals
- Press Release Jun 24 2025
- Glenmark Launches a Transformative Nutrition and Livelihood Project in Emali, Kenya
- Press Release Jul 10 2025
- Press Release Aug 14 2025
- Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals